Assay Detail
Functional
CHEMBL5512986
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Antiviral activity against SARS-CoV-2 infected in African green monkey Vero E6 cells assessed as inhibition of viral replication incubated by plaque reduction assay
8
Total Activities
8
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Severe acute respiratory syndrome coronavirus 2 |
| Cell Type | Vero E6 |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Target
SARS-CoV-2 (CHEMBL4303835) ↗| Type | ORGANISM |
| Organism | Severe acute respiratory syndrome coronavirus 2 |
Publication
Development of de-novo coronavirus 3-chymotrypsin-like protease (3CL<sup>pro</sup>) inhibitors since COVID-19 outbreak: A strategy to tackle challenges of persistent virus infection.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| EC50 | 8 | 6.24 | 6.62 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL5564996 | — | — | 1 | 6.62 |
| CHEMBL4796938 | — | — | 1 | 6.28 |
| CHEMBL5276490 | — | — | 1 | 6.28 |
| CHEMBL5270743 | — | — | 1 | 6.27 |
| CHEMBL5288416 | — | — | 1 | 6.18 |
| CHEMBL5275166 | — | — | 1 | 6.17 |
| CHEMBL5267952 | — | — | 1 | 6.08 |
| CHEMBL5195325 | — | — | 1 | 6.07 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL5564996 | — | EC50 | = | 240.0 | nM | 6.62 |
| CHEMBL4796938 | — | EC50 | = | 530.0 | nM | 6.28 |
| CHEMBL5276490 | — | EC50 | = | 530.0 | nM | 6.28 |
| CHEMBL5270743 | — | EC50 | = | 540.0 | nM | 6.27 |
| CHEMBL5288416 | — | EC50 | = | 660.0 | nM | 6.18 |
| CHEMBL5275166 | — | EC50 | = | 670.0 | nM | 6.17 |
| CHEMBL5267952 | — | EC50 | = | 830.0 | nM | 6.08 |
| CHEMBL5195325 | — | EC50 | = | 860.0 | nM | 6.07 |